Skip to main content
260 search results for:

Glucocorticoids 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 21-06-2022 | Glucocorticoids | News | Article

    Low-dose glucocorticoids show no negative impact on BMD

    Indeed, a specific analysis of individuals with RA receiving 5 mg/day of glucocorticoids (n=138) showed no negative impact on BMD at any disease activity level.

  2. 03-08-2021 | Rheumatoid arthritis | News | Article

    RA vertebral fracture risk increased with low-dose glucocorticoids

    In patients with rheumatoid arthritis, low-dose glucocorticoids are associated with an increased risk for vertebral fracture, but not with overall or non-vertebral fractures, show findings from a UK-based retrospective cohort study.

  3. 06-09-2021 | COVID-19 | News | Article

    Glucocorticoids, B-cell depleting therapies may dampen immune response to COVID-19 vaccines

    Most people with inflammatory diseases treated with immunomodulatory therapies mount an antibody response to mRNA vaccines against SARS-CoV-2, but the response may be blunted in those taking glucocorticoids or B cell-depleting therapies, shows the COVaRiPAD study.

  4. 21-06-2021 | MIS-C | News | Article

    Studies evaluate effectiveness of IVIG, glucocorticoids for MIS-C

    Two real-world studies published in The New England Journal of Medicine draw conflicting conclusions on the effectiveness of treatment regimens involving intravenous immunoglobulin and glucocorticoids for the treatment of multisystem inflammatory disease in children.

  5. 20-01-2021 | Rheumatoid arthritis | News | Article
    News in brief

    ‘Excessive concerns’ about the safety of low-dose glucocorticoids

    Rheumatologists and patients with rheumatoid arthritis have concerns about the safety of low-dose glucocorticoids that “greatly exceed” evidence from published data, researchers report.

  6. 14-08-2020 | COVID-19 | News | Article

    Glucocorticoids, not anti-cytokine therapies, may worsen COVID-19 outcomes

    Three patients were taking methotrexate with or without glucocorticoids and one patient was taking a biologic DMARD.

  7. 21-09-2020 | Rheumatoid arthritis | News | Article

    Even low-dose glucocorticoids raise serious infection risk in RA patients

    In a model adjusting for potentially confounding factors, people taking any dose of glucocorticoids had a significantly higher risk for hospitalized infection than those not taking glucocorticoids, with a hazard ratio (HR) of 1.29 for those in the low-dose group, 1.72 for those in the medium-dose group, and 2.16 for those in the high-dose group.

  8. 21-09-2020 | Glucocorticoids | Highlight | Teaser
    medwireNews top story

    Even low-dose glucocorticoids raise serious infection risk in RA patients

    Among patients with rheumatoid arthritis receiving stable DMARD treatment, long-term glucocorticoid use is associated with a dose-dependent increase in the risk for serious infection, with a “small but significant” risk even at the lowest doses, researchers report.

  9. 22-07-2020 | COVID-19 | News | Article

    Promising results with glucocorticoids, tocilizumab for COVID-19-associated cytokine storm syndrome

    Writing in the press release, study co-author Robert Landewé said: “Our study shows that the sickest COVID-19 patients, namely those with signs of cytokine storm, had a dramatic beneficial effect on glucocorticoids.

  10. 13-11-2019 | Rheumatoid arthritis | ACR/ARP 2019 | Article

    Methotrexate plus glucocorticoids compare favorably with biologics in early RA

    The 95% confidence intervals for the differences between methotrexate plus glucocorticoids versus methotrexate plus certolizumab or tocilizumab did not cross the predefined noninferiority margin of 15%, making it statistically noninferior to these options.

  11. 28-05-2019 | Rheumatoid arthritis | Highlight | Teaser
    medwireNews top story

    Opioids, SSRIs, glucocorticoids implicated in RA fracture risk

    US research shows that the use of opioids, selective serotonin reuptake inhibitors, or glucocorticoids may increase the risk for all types of osteoporotic fracture in patients with rheumatoid arthritis.

  12. 24-05-2019 | Rheumatoid arthritis | News | Article

    Opioids, SSRIs, glucocorticoids implicated in RA fracture risk

    US research shows that the use of opioids, selective serotonin reuptake inhibitors, or glucocorticoids may increase the risk for all types of osteoporotic fracture in patients with rheumatoid arthritis.

  13. 22-10-2018 | Rheumatoid arthritis | News | Article

    Glucocorticoids add to increased herpes zoster risk in patients taking tofacitinib for RA

    The increased risk for herpes zoster in rheumatoid arthritis patients taking tofacitinib is further doubled with the concomitant use of glucocorticoids, show real-world data for more than 8000 patients.

  14. 27-10-2018 | Osteoporosis | Highlight | Teaser
    medwireNews@ACR/ARHP 2018

    Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

    Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

  15. play
    27-10-2018 | Denosumab | ACR/ARHP 2018 | Video

    Support for denosumab as a treatment option for osteoporosis in patients treated with glucocorticoids

    Kenneth Saag discusses his findings of a superior bone mineral density benefit at 2 years with denosumab versus risedronate in patients with glucocorticoid-related osteoporosis (4:45).

  16. 27-11-2017 | Rheumatoid arthritis | News | Article

    Glucocorticoids unlikely to influence tofacitinib efficacy in RA patients

    Concomitant use of glucocorticoids is unlikely to alter the efficacy of the Janus kinase inhibitor tofacitinib among patients with rheumatoid arthritis, results of a post-hoc analysis suggest.

  17. 19-06-2017 | Rheumatoid arthritis | EULAR 2017 | Article
    EULAR 2017

    Surprise findings for early high-dose glucocorticoids in RA treatment

    The addition of high-dose glucocorticoids to first-line adalimumab and methotrexate in the treatment of rheumatoid arthritis fails to further improve efficacy, results of a phase IV study show.

  18. 07-02-2018 | Rheumatoid arthritis | Article

    Effect of discontinuation or initiation of methotrexate or glucocorticoids on tofacitinib efficacy in patients with rheumatoid arthritis: A post hoc analysis

    Fleischmann R et al. Rheumatol Ther 2018; Advance online publication. doi: 10.1007/s40744-018-0093-7

  19. 02-07-2018 | Rheumatoid arthritis | Review | Article

    The 70th anniversary of glucocorticoids in rheumatic diseases: The second youth of an old friend

    Palmowski Y, Buttgereit T, Buttgereit F. Rheumatology (Oxford) 2018: key169. doi: Y10.1093/rheumatology/key169

  20. 07-12-2022 | Rheumatoid arthritis | News | Article

    Similar reduction in CV risk with different add-on RA treatments

    Participants were aged a median of 58.0 years, with a median RA duration of 1.4 years, and a third were taking glucocorticoids in addition to methotrexate.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.